Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance. (2021)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1128/aac.00293-21
PubMed Identifier: 33972238
Publication URI: http://europepmc.org/abstract/MED/33972238
Type: Journal Article/Review
Volume: 65
Parent Publication: Antimicrobial agents and chemotherapy
Issue: 7
ISSN: 0066-4804